SANJIVANI PARANTERAL
|
SANJIVANI PARANTERAL Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Profit Before Tax | ₹10 Cr | ₹7.57 Cr |
| Adjustment | ₹0.73 Cr | ₹0.77 Cr |
| Changes In working Capital | ₹2.64 Cr | ₹-18 Cr |
| Cash Flow after changes in Working Capital | ₹14 Cr | ₹-9.59 Cr |
| Cash Flow from Operating Activities | ₹12 Cr | ₹-11 Cr |
| Cash Flow from Investing Activities | ₹-22 Cr | ₹-12 Cr |
| Cash Flow from Financing Activities | ₹10 Cr | ₹23 Cr |
| Net Cash Inflow / Outflow | ₹0.94 Cr | ₹0.24 Cr |
| Opening Cash & Cash Equivalents | ₹0.54 Cr | ₹0.30 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
| Effect of Foreign Exchange Fluctuations | - | - |
| Closing Cash & Cash Equivalent | ₹1.49 Cr | ₹0.54 Cr |
Compare Cashflow Statement of peers of SANJIVANI PARANTERAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SANJIVANI PARANTERAL | ₹236.7 Cr | 1.3% | 18.4% | -26.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
SANJIVANI PARANTERAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANJIVANI PARANTERAL | 1.3% |
18.4% |
-26.2% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses